Clinical trial
A Single-Center, Exploratory Clinical Study Combining Radiofrequency and Pulsed Field Ablation for Persistent Atrial Fibrillation Based on Columbus™ 3D EP Navigation System
NCT06232798 is registered in ClinicalTrials.gov with Shanghai MicroPort EP MedTech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center, Exploratory Clinical Study Combining Radiofrequency and Pulsed Field Ablation for Persistent Atrial Fibrillation Based on Columbus™ 3D EP Navigation System
- Lead sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 11, 2024
- Completion date
- April 30, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
persistent atrial fibrillation